Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MasterCraft Agrees to Sell Merritt Island Boat Manufacturing Plant
-
Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders’ Meeting
-
Fortune Media and Great Place To Work Name Anteriad to 2024 Best Workplaces in Advertising & Marketing List
-
Resilinc Enhances its Collaboration Platform for Superior Sub-Tier Visibility and Accelerated Mitigation Responses
-
Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference
-
TransUnion and Truework Enable Rental Screening with Income & Employment Verification for Property Managers in a Single Click
-
Baker Hughes Announces Dates for Third-quarter 2024 Earnings Release and Webcast
-
Michelin : Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
Giyani Announces Senior Leadership Change
-
Fortune Media and Great Place To Work Name Ensemble to 2024 Best Workplaces in Health Care List
-
Scatec signs PPA for 1 GW solar and 100 MW/200 MWh battery storage project in Egypt
-
Kvika banki hf.: Transaction in relation to a share buyback programme - buy back is completed
-
Petrolympic initiate a Drilling Campaign on Vauquelin gold and base metals Property in Val-d’Or, Québec
-
Amesite Launches NurseMagic™ Pilot Programs with Five Healthcare Companies
-
FTI Consulting Adds EY-Parthenon Leader to Build Industry Depth and Launch FTI Delta’s New Consumer & Retail Practice
-
Kelly Announces Chief Financial Officer Transition
-
Intellia Therapeutics to Present Data from the Phase 2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the 2024 ACAAI Annual Scientific Meeting
-
Lilium Welcomes Aerospace Industry Veteran Philippe Balducchi to Board of Directors
-
Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories
-
Sagimet Announces Oral Presentation at the 8th Annual MASH Drug Development Summit
-
FTI Consulting Adds EY-Parthenon Leader to Build Industry Depth and Launch FTI Delta’s New Consumer & Retail Practice
-
Biogen Board Appoints Two New Independent Directors
-
Skyharbour Appoints Athabasca Basin Veteran, Serdar Donmez, as Vice President of Exploration
-
Net Asset Value
-
VitalCaring’s AI-driven Cognitive Care Pilot Shows Promising Results
-
Changes in the Management Board of Admiral Markets AS
-
Goliath Resources Upsizes Flow Through Financing To $12,750,000 And Strategic Shareholder Mr. Rob McEwen Buying 800,000 Shares Increasing Ownership To 3.8%
-
Oruka Therapeutics Announces $200 Million Private Placement
-
OrthoPediatrics Corp. Announces Launch of Enabling Technologies Division
-
INE Security Aligns with White House Plan to Close Cyber Skills Gap
-
Enthusiast Gaming Teams Up with Frigo Cheese Heads
-
AI Can’t Compete! Survey Exposes Why Students and Parents Are Choosing Human Tutors
-
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
-
Invivyd at the Ready for Upcoming Respiratory Virus Season with PEMGARDA™ (pemivibart) to Help Protect Vulnerable Immunocompromised Persons from COVID-19
-
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
-
Vironexis Biotherapeutics Launches with FDA Clearance of IND Application for First-Ever Clinical Trial of an AAV-delivered Cancer Immunotherapy
-
Aya Gold & Silver Announces Spinout and Creation of Growth-Focused Gold Venture
-
Biosplice Therapeutics Announces Initiation of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Trial Sponsored by the National Cancer Institute (NCI)
-
Circe Announces $5M Seed Round and Pilot Plant
-
Atana Wins Two Brandon Hall Group HCM Excellence Awards
-
Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
-
SEED Therapeutics Appoints Eisai Co., Ltd.’s Dr. Yoshiharu Mizui to Board of Directors
-
Operant AI Secures $10M Series A to Protect the Modern Cloud Across APIs, Applications and AI
-
Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
-
Realm.Security Emerges from Stealth, Raises $5M to Manage Explosion of Cyber Security Data
-
F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US
-
ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive
-
Yodeck Expands Global Partner Program to Generate New Service Offerings and Revenue Opportunities for Yodeck Partners
-
Aduro Clean Technologies Reports 2024 Financial Results and Provides End of Year Update
-
Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23
